Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Ligand Pharmaceuticals Inc (LGND)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Dorset Management

David M. Knott

998,100 $101,417 51.03%
2.
Cardinal Capital

Amy Minella

767,485 $77,984 +14% 3.34%
3.
CQS Cayman LPBOND

Michael Hintze

15,000,000 $21,717 +25% 1.72%
4.
Scopia Capital

Matt Sirovich And Jeremy Mindich

520,448 $52,883 1%
5.
Highbridge Capital ManagementBOND

Glenn Russell Dubin

25,000,000 $36,172 0.64%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaning Holdings Date Form 4
$45.23 126 Officer 27,433 2014-12-31 Filing
$45.23 46 Officer 55,016 2014-12-31 Filing
$45.23 103 Officer 2,831 2014-12-31 Filing
$45.68 2,000 Director 49,286 2014-10-15 Filing
$44.91 85 Officer 53,970 2014-10-10 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$109.10 4,000 Officer, Director 139,171 2017-03-20 Filing
$107.06 4,000 Officer, Director 128,969 2017-03-08 Filing
$103.39 6,879 Officer 90,720 2017-03-02 Filing
$107.58 7,000 Director 153,898 2017-02-28 Filing
$106.00 25,000 Director 160,898 2017-02-27 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 191,883 $19,497 4.03%
2. 124,530 $12,653 2.59%
3. 23,785 $2,417 2.55%
4. 77,922 $7,918 2.36%
5. 8,100,000 $11,729 2.32%
News See All